Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01469871
Other study ID # PEJ-481
Secondary ID
Status Completed
Phase Phase 4
First received November 4, 2011
Last updated November 9, 2011
Start date February 2009
Est. completion date January 2010

Study information

Verified date November 2011
Source Hopital de l'Enfant-Jesus
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine if one of the new types of dressings (MEPORE PRO and/or MEPILEX BORDER ) will reduce the blister rate compared to the currently used HYPAFIX.


Recruitment information / eligibility

Status Completed
Enrollment 150
Est. completion date January 2010
Est. primary completion date January 2010
Accepts healthy volunteers No
Gender Both
Age group 45 Years and older
Eligibility Inclusion Criteria:

- Male or Female 45 years old or older

- Hip surgery at Hopital de l'Enfant-Jesus between 02/2009 and 01/2010 (THR,rTHR, DHS, screw fixation, hemiarthroplasty, resurfacing)

- Signed consent form

Exclusion Criteria:

- Allergy to dressing

- Polytrauma / high energy trauma

- Wound at the surgical site prior to surgery

- Neurological deficit of operated side (hemiplegia, etc.)

- Bilateral fracture

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Device:
Dressing of wound
The wound will be dressed using the Hypafix Transparent dressing after hip surgery.
Dressing of wound
The wound will be dressed using the Mepore Pro dressing after hip surgery.
Dressing of wound
The wound will be dressed using the Mepilex Border dressing after hip surgery.

Locations

Country Name City State
Canada Centre hospitalier affilié universitaire de Quebec - Hopital l'Enfant-Jesus Quebec

Sponsors (1)

Lead Sponsor Collaborator
Hopital de l'Enfant-Jesus

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary The prevalence of tape blisters after hip fracture surgery Participants will be followed for the duration of hospital stay, an expected average of 8 days No
Secondary Length of hospital stay Participants will be followed for the duration of hospital stay, an expected average of 8 days No
Secondary The correlation between risk factors and tape blisters Participants will be followed for the duration of hospital stay, an expected average of 8 days No
Secondary The possible link between the presence of tape blisters and hospital morbidity. Participants will be followed for the duration of hospital stay, an expected average of 8 days No
Secondary The costs related to a tape blister. The actual costs related to a tape blister will be calculated by adding the costs of additional dressings, the costs associated with an extended hospital stay and the additional costs associated with the use of external resources. Participants will be followed for the duration of hospital stay, an expected average of 8 days No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06033651 - Long Term Follow up of the Titanium Modular Revision Hip System, With Review of Metal Ion Levels
Completed NCT05802589 - Comparison of the Efficiency of PENG Block and ESP Block Used for Postoperative Analgesia in Elective Hip Surgery N/A
Completed NCT03954730 - Eccentric Training Versus Active Release Technique On Quadriceps In Patients With Dynamic Hip Screw N/A
Recruiting NCT06166602 - US-guided Pericapsular Nerve Group (PENG) Block in Different Volumes on Postoperative Pain in Hip Replacement Surgeries N/A
Recruiting NCT05384860 - Incorporating Acupuncture Into ERAS for Ambulatory Total Hip Replacement (THR) Surgery N/A
Completed NCT01875289 - Efficacy of a Modified Obturator Nerve Block Technique N/A
Recruiting NCT05460442 - Pericapsular Nerve Group Block Versus Fascia Iliaca Block for Pediatric Hip Surgery N/A
Terminated NCT03435692 - Post Operative Pain Control After Pediatric Hip Surgery N/A
Not yet recruiting NCT05966220 - Post Market Clinical Follow-up of Hip Surgery Using FH ORTHO Company Medical Devices. N/A
Completed NCT00890123 - Preoperative Intravenous Omega 3 Fatty Acids Administration in Elderly Patients Undergoing Hip Surgery Phase 4
Completed NCT03190447 - Wich is the Best Dressing in Wounds by Primary Surgery of THA and / or TKA? N/A